Table 5 HLA-DQB1 allele frequency in patients with ESRD and controls.
From: Associations between end stage renal disease and HLA polymorphisms in the Guangxi Zhuang population
|  | ESRD (2n = 650) | Control (2n = 700) | P | Pc | OR | 95% CI | ||
|---|---|---|---|---|---|---|---|---|
NO. | AF (%) | NO. | AF (%) | |||||
05:02 | 220 | 33.85 | 245 | 35.00 | 0.656 | NS | 0.950 | 0.759–1.190 |
03:01 | 111 | 17.08 | 91 | 13.00 | 0.036 | NS | 1.378 | 1.021–1.861 |
06:01 | 85 | 13.08 | 84 | 12.00 | 0.550 | NS | 1.103 | 0.799–1.523 |
02:01 | 56 | 8.62 | 80 | 11.43 | 0.086 | NS | 0.731 | 0.510–1.047 |
05:03 | 38 | 5.85 | 37 | 5.29 | 0.653 | NS | 1.113 | 0.698–1.773 |
03:03 | 32 | 4.92 | 52 | 7.43 | 0.057 | NS | 0.645 | 0.410–1.016 |
05:01 | 31 | 4.77 | 43 | 6.14 | 0.268 | NS | 0.765 | 0.476–1.230 |
04:01 | 27 | 4.15 | 19 | 2.71 | 0.145 | NS | 1.553 | 0.855–2.822 |
03:02 | 20 | 3.08 | 12 | 1.71 | 0.100 | NS | 1.820 | 0.883–3.753 |
02:02 | 12 | 1.85 | 8 | 1.14 | 0.285 | NS | 1.627 | 0.661–4.006 |
06:02 | 7 | 1.08 | 12 | 1.71 | 0.321 | NS | 0.624 | 0.244–1.595 |
04:02 | 4 | 0.62 | 5 | 0.71 | 1.000 | NS | 0.861 | 0.230–3.219 |
06:10 | 4 | 0.62 | 4 | 0.57 | 1.000 | NS | 1.077 | 0.268–4.326 |
06:04 | 2 | 0.31 | 3 | 0.43 | 1.000 | NS | 0.717 | 0.119–4.305 |
06:09 | 1 | 0.15 | 5 | 0.71 | 0.220 | NS | 0.214 | 0.025–1.838 |
